Detalhe da pesquisa
1.
Diagnosis and management of gastric-type endocervical adenocarcinoma: A case report and review of the literature.
Gynecol Oncol
; 185: 165-172, 2024 Feb 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38428332
2.
Cost-effectiveness of chemotherapy and dostarlimab for advanced or recurrent endometrial cancer.
Gynecol Oncol
; 183: 78-84, 2024 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38554477
3.
Phase 1b study of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate, in combination with carboplatin and bevacizumab in patients with platinum-sensitive ovarian cancer.
Gynecol Oncol
; 185: 186-193, 2024 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38447347
4.
Does the choice of platinum doublet matter? A study to evaluate the impact of platinum doublet choice for treatment of platinum-sensitive ovarian cancer recurrence on the development of future PARP inhibitor and platinum resistance.
Gynecol Oncol
; 182: 51-56, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38262238
5.
A phase 2 trial exploring the significance of homologous recombination status in patients with platinum sensitive or platinum resistant relapsed ovarian cancer receiving combination cediranib and olaparib.
Gynecol Oncol
; 187: 105-112, 2024 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38759516
6.
Prospective evaluation of the tolerability and efficacy of niraparib dosing based on baseline body weight and platelet count: Results from the PRIMA/ENGOT-OV26/GOG-3012 trial.
Cancer
; 129(12): 1846-1855, 2023 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37060236
7.
Trametinib versus standard of care in patients with recurrent low-grade serous ovarian cancer (GOG 281/LOGS): an international, randomised, open-label, multicentre, phase 2/3 trial.
Lancet
; 399(10324): 541-553, 2022 02 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35123694
8.
The right time for change: A report on the heterogeneity of IVB endometrial cancer and improved risk-stratification provided by new 2023 FIGO staging criteria.
Gynecol Oncol
; 175: 32-40, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37321153
9.
"More than a song and dance": Exploration of patient perspectives and educational quality of gynecologic cancer content on TikTok.
Gynecol Oncol
; 175: 81-87, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37329872
10.
Malnutrition, sarcopenia, and cancer cachexia in gynecologic cancer.
Gynecol Oncol
; 175: 142-155, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37385068
11.
Safety and efficacy of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with bevacizumab in patients with platinum-resistant ovarian cancer.
Gynecol Oncol
; 170: 241-247, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36736157
12.
Prevalence of type 2 diabetes diagnoses in the perioperative and survivorship periods following surgical management of endometrial cancer: An opportunity for screening and intervention?
Gynecol Oncol
; 177: 46-52, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37639902
13.
DKK1 is a predictive biomarker for response to DKN-01: Results of a phase 2 basket study in women with recurrent endometrial carcinoma.
Gynecol Oncol
; 172: 82-91, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37001446
14.
Glassy cell carcinoma of the cervix: Findings from a combined National Cancer Database analysis and single institution review of treatment patterns and outcomes.
Gynecol Oncol
; 173: 15-21, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37037083
15.
The impact of antibiotic and proton pump inhibitor use at the time of adjuvant platinum-based chemotherapy on survival in patients with endometrial cancer.
Gynecol Oncol
; 178: 14-22, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37741201
16.
Niraparib and dostarlimab for the treatment of recurrent platinum-resistant ovarian cancer: results of a Phase II study (MOONSTONE/GOG-3032).
Gynecol Oncol
; 178: 161-169, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37890345
17.
Postoperative venous thromboembolism risk stratification in patients with uterine cancer.
Am J Obstet Gynecol
; 228(5): 555.e1-555.e8, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36574873
18.
Less is more: clinical utility of postoperative laboratory testing following minimally invasive hysterectomy for endometrial cancer.
Am J Obstet Gynecol
; 228(1): 59.e1-59.e13, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35931127
19.
A plain language summary of results from the GARNET study of dostarlimab in patients with endometrial cancer.
Future Oncol
; 19(25): 1709-1714, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37381977
20.
ARTISTRY-7: phase III trial of nemvaleukin alfa plus pembrolizumab vs chemotherapy for platinum-resistant ovarian cancer.
Future Oncol
; 19(23): 1577-1591, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37334673